HEADER TRANSFERASE/TRANSFERASE INHIBITOR 03-MAY-12 4F08 TITLE DISCOVERY AND OPTIMIZATION OF C-2 METHYL IMIDAZO-PYRROLOPYRIDINES AS TITLE 2 POTENT AND ORALLY BIOAVAILABLE JAK1 INHIBITORS WITH SELECTIVITY OVER TITLE 3 JAK2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 833-1132; COMPND 5 SYNONYM: JANUS KINASE 2, JAK-2; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK2, JAK2 KINASE DOMAIN; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS JAK2, KINASE DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.M.MURRAY REVDAT 5 06-DEC-23 4F08 1 REMARK REVDAT 4 13-SEP-23 4F08 1 REMARK SEQADV LINK REVDAT 3 29-MAY-13 4F08 1 HET HETNAM REMARK FORMUL REVDAT 2 25-JUL-12 4F08 1 JRNL REMARK REVDAT 1 04-JUL-12 4F08 0 JRNL AUTH M.ZAK,R.MENDONCA,M.BALAZS,K.BARRETT,P.BERGERON,W.S.BLAIR, JRNL AUTH 2 C.CHANG,G.DESHMUKH,J.DEVOSS,P.S.DRAGOVICH,C.EIGENBROT, JRNL AUTH 3 N.GHILARDI,P.GIBBONS,S.GRADL,C.HAMMAN,E.J.HANAN,E.HARSTAD, JRNL AUTH 4 P.R.HEWITT,C.A.HURLEY,T.JIN,A.JOHNSON,T.JOHNSON,J.R.KENNY, JRNL AUTH 5 M.F.KOEHLER,P.BIR KOHLI,J.J.KULAGOWSKI,S.LABADIE,J.LIAO, JRNL AUTH 6 M.LIIMATTA,Z.LIN,P.J.LUPARDUS,R.J.MAXEY,J.M.MURRAY,R.PULK, JRNL AUTH 7 M.RODRIGUEZ,S.SAVAGE,S.SHIA,M.STEFFEK,S.UBHAYAKAR,M.ULTSCH, JRNL AUTH 8 A.VAN ABBEMA,S.I.WARD,L.XIAO,Y.XIAO JRNL TITL DISCOVERY AND OPTIMIZATION OF C-2 METHYL JRNL TITL 2 IMIDAZOPYRROLOPYRIDINES AS POTENT AND ORALLY BIOAVAILABLE JRNL TITL 3 JAK1 INHIBITORS WITH SELECTIVITY OVER JAK2. JRNL REF J.MED.CHEM. V. 55 6176 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22698084 JRNL DOI 10.1021/JM300628C REMARK 2 REMARK 2 RESOLUTION. 2.82 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.82 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.61 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 20852 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.960 REMARK 3 FREE R VALUE TEST SET COUNT : 1034 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.82 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.97 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.63 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2961 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2483 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2809 REMARK 3 BIN R VALUE (WORKING SET) : 0.2468 REMARK 3 BIN FREE R VALUE : 0.2751 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.13 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 152 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4768 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 55.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 58.85 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.51670 REMARK 3 B22 (A**2) : -0.51670 REMARK 3 B33 (A**2) : 1.03340 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.399 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 1.024 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : NULL ; NULL ; NULL REMARK 3 BOND ANGLES : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : NULL ; NULL ; NULL REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4F08 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-MAY-12. REMARK 100 THE DEPOSITION ID IS D_1000072290. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-APR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20873 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.820 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.10200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.82 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.51800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2B7A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM ACETATE, 0.1M SODIUM REMARK 280 CITRATE PH6, 25% PEG 8000, PH 6.0, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.36600 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 17.68300 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 53.04900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 831 REMARK 465 SER A 832 REMARK 465 SER A 833 REMARK 465 GLY A 834 REMARK 465 ALA A 835 REMARK 465 PHE A 836 REMARK 465 GLU A 837 REMARK 465 ASP A 838 REMARK 465 ARG A 839 REMARK 465 ASP A 840 REMARK 465 PRO A 841 REMARK 465 THR A 842 REMARK 465 GLY B 831 REMARK 465 SER B 832 REMARK 465 SER B 833 REMARK 465 GLY B 834 REMARK 465 ALA B 835 REMARK 465 PHE B 836 REMARK 465 GLU B 837 REMARK 465 ASP B 838 REMARK 465 ARG B 839 REMARK 465 ASP B 840 REMARK 465 PRO B 841 REMARK 465 THR B 842 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 893 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 922 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 860 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG B 893 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 922 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 923 CG CD NE CZ NH1 NH2 REMARK 470 LYS B1011 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 1104 NH1 ARG A 1122 2.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE1 GLN A 853 NH2 ARG B 947 1554 1.90 REMARK 500 OE1 GLN A 853 CZ ARG B 947 1554 2.05 REMARK 500 OE1 GLN A 853 NH1 ARG B 947 1554 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 887 61.94 -106.48 REMARK 500 ASP A 976 35.10 -143.96 REMARK 500 TRP A1106 52.07 -109.73 REMARK 500 ALA B 920 -13.21 87.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG B 947 0.29 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1RS A 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1RS B 1201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4F09 RELATED DB: PDB REMARK 900 RELATED ID: 4EI4 RELATED DB: PDB REMARK 900 RELATED ID: 4EHZ RELATED DB: PDB DBREF 4F08 A 833 1132 UNP O60674 JAK2_HUMAN 833 1132 DBREF 4F08 B 833 1132 UNP O60674 JAK2_HUMAN 833 1132 SEQADV 4F08 GLY A 831 UNP O60674 EXPRESSION TAG SEQADV 4F08 SER A 832 UNP O60674 EXPRESSION TAG SEQADV 4F08 GLY B 831 UNP O60674 EXPRESSION TAG SEQADV 4F08 SER B 832 UNP O60674 EXPRESSION TAG SEQRES 1 A 302 GLY SER SER GLY ALA PHE GLU ASP ARG ASP PRO THR GLN SEQRES 2 A 302 PHE GLU GLU ARG HIS LEU LYS PHE LEU GLN GLN LEU GLY SEQRES 3 A 302 LYS GLY ASN PHE GLY SER VAL GLU MET CYS ARG TYR ASP SEQRES 4 A 302 PRO LEU GLN ASP ASN THR GLY GLU VAL VAL ALA VAL LYS SEQRES 5 A 302 LYS LEU GLN HIS SER THR GLU GLU HIS LEU ARG ASP PHE SEQRES 6 A 302 GLU ARG GLU ILE GLU ILE LEU LYS SER LEU GLN HIS ASP SEQRES 7 A 302 ASN ILE VAL LYS TYR LYS GLY VAL CYS TYR SER ALA GLY SEQRES 8 A 302 ARG ARG ASN LEU LYS LEU ILE MET GLU TYR LEU PRO TYR SEQRES 9 A 302 GLY SER LEU ARG ASP TYR LEU GLN LYS HIS LYS GLU ARG SEQRES 10 A 302 ILE ASP HIS ILE LYS LEU LEU GLN TYR THR SER GLN ILE SEQRES 11 A 302 CYS LYS GLY MET GLU TYR LEU GLY THR LYS ARG TYR ILE SEQRES 12 A 302 HIS ARG ASP LEU ALA THR ARG ASN ILE LEU VAL GLU ASN SEQRES 13 A 302 GLU ASN ARG VAL LYS ILE GLY ASP PHE GLY LEU THR LYS SEQRES 14 A 302 VAL LEU PRO GLN ASP LYS GLU PTR PTR LYS VAL LYS GLU SEQRES 15 A 302 PRO GLY GLU SER PRO ILE PHE TRP TYR ALA PRO GLU SER SEQRES 16 A 302 LEU THR GLU SER LYS PHE SER VAL ALA SER ASP VAL TRP SEQRES 17 A 302 SER PHE GLY VAL VAL LEU TYR GLU LEU PHE THR TYR ILE SEQRES 18 A 302 GLU LYS SER LYS SER PRO PRO ALA GLU PHE MET ARG MET SEQRES 19 A 302 ILE GLY ASN ASP LYS GLN GLY GLN MET ILE VAL PHE HIS SEQRES 20 A 302 LEU ILE GLU LEU LEU LYS ASN ASN GLY ARG LEU PRO ARG SEQRES 21 A 302 PRO ASP GLY CYS PRO ASP GLU ILE TYR MET ILE MET THR SEQRES 22 A 302 GLU CYS TRP ASN ASN ASN VAL ASN GLN ARG PRO SER PHE SEQRES 23 A 302 ARG ASP LEU ALA LEU ARG VAL ASP GLN ILE ARG ASP ASN SEQRES 24 A 302 MET ALA GLY SEQRES 1 B 302 GLY SER SER GLY ALA PHE GLU ASP ARG ASP PRO THR GLN SEQRES 2 B 302 PHE GLU GLU ARG HIS LEU LYS PHE LEU GLN GLN LEU GLY SEQRES 3 B 302 LYS GLY ASN PHE GLY SER VAL GLU MET CYS ARG TYR ASP SEQRES 4 B 302 PRO LEU GLN ASP ASN THR GLY GLU VAL VAL ALA VAL LYS SEQRES 5 B 302 LYS LEU GLN HIS SER THR GLU GLU HIS LEU ARG ASP PHE SEQRES 6 B 302 GLU ARG GLU ILE GLU ILE LEU LYS SER LEU GLN HIS ASP SEQRES 7 B 302 ASN ILE VAL LYS TYR LYS GLY VAL CYS TYR SER ALA GLY SEQRES 8 B 302 ARG ARG ASN LEU LYS LEU ILE MET GLU TYR LEU PRO TYR SEQRES 9 B 302 GLY SER LEU ARG ASP TYR LEU GLN LYS HIS LYS GLU ARG SEQRES 10 B 302 ILE ASP HIS ILE LYS LEU LEU GLN TYR THR SER GLN ILE SEQRES 11 B 302 CYS LYS GLY MET GLU TYR LEU GLY THR LYS ARG TYR ILE SEQRES 12 B 302 HIS ARG ASP LEU ALA THR ARG ASN ILE LEU VAL GLU ASN SEQRES 13 B 302 GLU ASN ARG VAL LYS ILE GLY ASP PHE GLY LEU THR LYS SEQRES 14 B 302 VAL LEU PRO GLN ASP LYS GLU PTR PTR LYS VAL LYS GLU SEQRES 15 B 302 PRO GLY GLU SER PRO ILE PHE TRP TYR ALA PRO GLU SER SEQRES 16 B 302 LEU THR GLU SER LYS PHE SER VAL ALA SER ASP VAL TRP SEQRES 17 B 302 SER PHE GLY VAL VAL LEU TYR GLU LEU PHE THR TYR ILE SEQRES 18 B 302 GLU LYS SER LYS SER PRO PRO ALA GLU PHE MET ARG MET SEQRES 19 B 302 ILE GLY ASN ASP LYS GLN GLY GLN MET ILE VAL PHE HIS SEQRES 20 B 302 LEU ILE GLU LEU LEU LYS ASN ASN GLY ARG LEU PRO ARG SEQRES 21 B 302 PRO ASP GLY CYS PRO ASP GLU ILE TYR MET ILE MET THR SEQRES 22 B 302 GLU CYS TRP ASN ASN ASN VAL ASN GLN ARG PRO SER PHE SEQRES 23 B 302 ARG ASP LEU ALA LEU ARG VAL ASP GLN ILE ARG ASP ASN SEQRES 24 B 302 MET ALA GLY MODRES 4F08 PTR A 1007 TYR O-PHOSPHOTYROSINE MODRES 4F08 PTR A 1008 TYR O-PHOSPHOTYROSINE MODRES 4F08 PTR B 1007 TYR O-PHOSPHOTYROSINE MODRES 4F08 PTR B 1008 TYR O-PHOSPHOTYROSINE HET PTR A1007 16 HET PTR A1008 16 HET PTR B1007 16 HET PTR B1008 16 HET 1RS A1201 18 HET 1RS B1201 18 HETNAM PTR O-PHOSPHOTYROSINE HETNAM 1RS 1-(PIPERIDIN-4-YL)-1,6-DIHYDROIMIDAZO[4,5-D]PYRROLO[2, HETNAM 2 1RS 3-B]PYRIDINE HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 4(C9 H12 N O6 P) FORMUL 3 1RS 2(C13 H15 N5) HELIX 1 1 GLU A 845 ARG A 847 5 3 HELIX 2 2 THR A 888 SER A 904 1 17 HELIX 3 3 SER A 936 HIS A 944 1 9 HELIX 4 4 ASP A 949 LYS A 970 1 22 HELIX 5 5 PRO A 1017 TYR A 1021 5 5 HELIX 6 6 ALA A 1022 SER A 1029 1 8 HELIX 7 7 VAL A 1033 THR A 1049 1 17 HELIX 8 8 GLU A 1052 LYS A 1055 5 4 HELIX 9 9 SER A 1056 GLY A 1066 1 11 HELIX 10 10 GLY A 1071 ASN A 1084 1 14 HELIX 11 11 PRO A 1095 TRP A 1106 1 12 HELIX 12 12 ASN A 1109 ARG A 1113 5 5 HELIX 13 13 SER A 1115 GLY A 1132 1 18 HELIX 14 14 GLU B 845 ARG B 847 5 3 HELIX 15 15 THR B 888 SER B 904 1 17 HELIX 16 16 SER B 936 HIS B 944 1 9 HELIX 17 17 ASP B 949 THR B 969 1 21 HELIX 18 18 PRO B 1017 TYR B 1021 5 5 HELIX 19 19 ALA B 1022 SER B 1029 1 8 HELIX 20 20 VAL B 1033 THR B 1049 1 17 HELIX 21 21 GLU B 1052 LYS B 1055 5 4 HELIX 22 22 SER B 1056 GLY B 1066 1 11 HELIX 23 23 GLY B 1071 ASN B 1084 1 14 HELIX 24 24 PRO B 1095 TRP B 1106 1 12 HELIX 25 25 ASN B 1109 ARG B 1113 5 5 HELIX 26 26 SER B 1115 GLY B 1132 1 18 SHEET 1 A 5 LEU A 849 LYS A 857 0 SHEET 2 A 5 GLY A 861 TYR A 868 -1 O VAL A 863 N LEU A 855 SHEET 3 A 5 VAL A 878 LEU A 884 -1 O VAL A 879 N CYS A 866 SHEET 4 A 5 LYS A 926 GLU A 930 -1 O MET A 929 N ALA A 880 SHEET 5 A 5 TYR A 913 CYS A 917 -1 N GLY A 915 O ILE A 928 SHEET 1 B 2 TYR A 972 ILE A 973 0 SHEET 2 B 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 C 2 ILE A 982 ASN A 986 0 SHEET 2 C 2 ARG A 989 ILE A 992 -1 O LYS A 991 N LEU A 983 SHEET 1 D 2 PTR A1007 LYS A1009 0 SHEET 2 D 2 LYS A1030 SER A1032 -1 O PHE A1031 N PTR A1008 SHEET 1 E 5 LEU B 849 LYS B 857 0 SHEET 2 E 5 GLY B 861 TYR B 868 -1 O VAL B 863 N LEU B 855 SHEET 3 E 5 VAL B 878 LEU B 884 -1 O VAL B 879 N CYS B 866 SHEET 4 E 5 LYS B 926 GLU B 930 -1 O MET B 929 N ALA B 880 SHEET 5 E 5 TYR B 913 CYS B 917 -1 N GLY B 915 O ILE B 928 SHEET 1 F 2 TYR B 972 ILE B 973 0 SHEET 2 F 2 LYS B 999 VAL B1000 -1 O LYS B 999 N ILE B 973 SHEET 1 G 2 ILE B 982 ASN B 986 0 SHEET 2 G 2 ARG B 989 ILE B 992 -1 O LYS B 991 N LEU B 983 SHEET 1 H 2 PTR B1007 LYS B1009 0 SHEET 2 H 2 LYS B1030 SER B1032 -1 O PHE B1031 N PTR B1008 LINK C GLU A1006 N PTR A1007 1555 1555 1.34 LINK C PTR A1007 N PTR A1008 1555 1555 1.33 LINK C PTR A1008 N LYS A1009 1555 1555 1.34 LINK C GLU B1006 N PTR B1007 1555 1555 1.33 LINK C PTR B1007 N PTR B1008 1555 1555 1.33 LINK C PTR B1008 N LYS B1009 1555 1555 1.34 CISPEP 1 ALA A 920 GLY A 921 0 -2.20 CISPEP 2 GLY B 921 ARG B 922 0 -0.02 SITE 1 AC1 9 LEU A 855 GLY A 856 VAL A 863 ALA A 880 SITE 2 AC1 9 GLU A 930 TYR A 931 LEU A 932 GLY A 935 SITE 3 AC1 9 LEU A 983 SITE 1 AC2 6 LEU B 855 ALA B 880 GLU B 930 TYR B 931 SITE 2 AC2 6 LEU B 932 LEU B 983 CRYST1 110.923 110.923 70.732 90.00 90.00 90.00 P 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009015 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009015 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014138 0.00000